Literature DB >> 15645586

Family experience with palliative sedation therapy for terminally ill cancer patients.

Tatsuya Morita1, Masayuki Ikenaga, Isamu Adachi, Itaru Narabayashi, Yoshiyuki Kizawa, Yoshifumi Honke, Hiroyuki Kohara, Taketo Mukaiyama, Tatsuo Akechi, Yosuke Uchitomi.   

Abstract

Symptomatic sedation is often required in terminally ill cancer patients, and could cause significant distress to their family. The aims of this study were to clarify the family experience during palliative sedation therapy, including their satisfaction and distress levels, and the determinants of family dissatisfaction and high-level distress. A multicenter questionnaire survey assessed 280 bereaved families of cancer patients who received sedation in 7 palliative care units in Japan. A total of 185 responses were analyzed(response rate, 73%). The families reported that 69% of the patients were considerably or very distressed before sedation. Fifty-five percent of the patients expressed an explicit wish for sedation, and 89% of families were clearly informed. Overall, 78% of the families were satisfied with the treatment, whereas 25% expressed a high level of emotional distress. The independent determinants of low levels of family satisfaction were: poor symptom palliation after sedation, insufficient information-giving, concerns that sedation might shorten the patient's life, and feelings that there might be other ways to achieve symptom relief The independent determinants of high levels of family distress were: poor symptom palliation after sedation, feeling the burden of responsibility for the decision, feeling unprepared for changes in the patient's condition, feeling that the physicians and nurses were not sufficiently compassionate, and shorter interval to patient death. Palliative sedation therapy was principally performed to relieve severe suffering based on family and patient consent. Although the majority of families were comfortable with this practice, clinicians should minimize family distress by regular monitoring of patient distress and timely modification of sedation protocols, providing sufficient information, sharing the responsibility of the decision, facilitating grief and providing emotional support.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15645586     DOI: 10.1016/j.jpainsymman.2004.03.004

Source DB:  PubMed          Journal:  J Pain Symptom Manage        ISSN: 0885-3924            Impact factor:   3.612


  15 in total

1.  [Austrian guideline for palliative sedation therapy (long version) : Results of a Delphi process of the Austrian Palliative Society (OPG)].

Authors:  Dietmar Weixler; Sophie Roider-Schur; Rudolf Likar; Claudia Bozzaro; Thomas Daniczek; Angelika Feichtner; Christoph Gabl; Bernhard Hammerl-Ferrari; Maria Kletecka-Pulker; Ulrich H J Körtner; Hilde Kössler; Johannes G Meran; Aurelia Miksovsky; Bettina Pusswald; Thomas Wienerroither; Herbert Watzke
Journal:  Wien Med Wochenschr       Date:  2016-12-06

2.  Making sense of continuous sedation in end-of-life care for cancer patients: an interview study with bereaved relatives in three European countries.

Authors:  S M Bruinsma; J Brown; A van der Heide; L Deliens; L Anquinet; S A Payne; J E Seymour; J A C Rietjens
Journal:  Support Care Cancer       Date:  2014-07-15       Impact factor: 3.603

3.  Current debates on end-of-life sedation: an international expert elicitation study.

Authors:  Evangelia Evie Papavasiliou; Sheila Payne; Sarah Brearley
Journal:  Support Care Cancer       Date:  2014-03-20       Impact factor: 3.603

4.  [Palliative sedation for psycho-existential suffering].

Authors:  Eva Weichselbaumer; Dietmar Weixler
Journal:  Wien Med Wochenschr       Date:  2013-10-25

5.  Considerations about hastening death among parents of children who die of cancer.

Authors:  Veronica Dussel; Steven Joffe; Joanne M Hilden; Jan Watterson-Schaeffer; Jane C Weeks; Joanne Wolfe
Journal:  Arch Pediatr Adolesc Med       Date:  2010-03

6.  Patient and/or family controlled palliative sedation with midazolam for intractable symptom control: a case series.

Authors:  Diamanto Aretha; Eleftheria S Panteli; Panagiotis Kiekkas; Menelaos Karanikolas
Journal:  Cases J       Date:  2009-02-11

Review 7.  Delirium in patients with cancer: assessment, impact, mechanisms and management.

Authors:  Peter G Lawlor; Shirley H Bush
Journal:  Nat Rev Clin Oncol       Date:  2014-09-02       Impact factor: 66.675

8.  Concerns of family members of patients receiving palliative sedation therapy.

Authors:  Tatsuya Morita; Masayuki Ikenaga; Isamu Adachi; Itaru Narabayashi; Yoshiyuki Kizawa; Yoshifumi Honke; Hiroyuki Kohara; Taketo Mukaiyama; Tatsuo Akechi; Yukie Kurihara; Yosuke Uchitomi
Journal:  Support Care Cancer       Date:  2004-09-15       Impact factor: 3.603

9.  The perspectives of clinical staff and bereaved informal care-givers on the use of continuous sedation until death for cancer patients: The study protocol of the UNBIASED study.

Authors:  Jane Seymour; Judith Rietjens; Jayne Brown; Agnes van der Heide; Sigrid Sterckx; Luc Deliens
Journal:  BMC Palliat Care       Date:  2011-03-04       Impact factor: 3.234

Review 10.  Palliative Sedation in End-of-Life Patients in Eastern Asia: A Narrative Review.

Authors:  Seung Hun Lee; Jung Hye Kwon; Young-Woong Won; Jung Hun Kang
Journal:  Cancer Res Treat       Date:  2022-04-19       Impact factor: 5.036

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.